Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human gene therapy: present and future.

M A Kay1, K P Ponder, S L Woo

  • 1Department of Cell Biology, Baylor College of Medicine, Houston TX 77030.

Breast Cancer Research and Treatment
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of physical activity on mother-child relationship and parental attitudes: a follow-up study examining the long-term effects of COVID-19.

European review for medical and pharmacological sciences·2023
Same author

Promoterless gene targeting without nucleases ameliorates haemophilia B in mice.

Nature·2014
Same author

Methods for delivery of genes to hepatocytes in vivo using recombinant adenovirus vectors.

Methods in molecular medicine·2014
Same author

Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma.

Oncogene·2013
Same author

Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B.

Haemophilia : the official journal of the World Federation of Hemophilia·2010
Same author

Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI.

Journal of inherited metabolic disease·2008
Same journal

Comments on: Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer.

Breast cancer research and treatment·2026
Same journal

Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy.

Breast cancer research and treatment·2026
Same journal

Discrimination, spectrum, and clinical utility: ICG lymphography drainage time in axillary staging.

Breast cancer research and treatment·2026
Same journal

Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimen.

Breast cancer research and treatment·2026
Same journal

Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study.

Breast cancer research and treatment·2026
Same journal

Subjective socioeconomic status moderates the relationship between objective neighborhood disadvantage and quality of life in middle- and older-aged women with breast cancer.

Breast cancer research and treatment·2026
See all related articles

Somatic gene therapy shows promise for hereditary deficiencies. Researchers successfully transduced hematopoietic and liver cells in animals, with ongoing human clinical trials demonstrating potential for future treatments.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Hematopoietic system and liver are key targets for somatic gene therapy.
  • Hereditary deficiencies present significant therapeutic challenges.

Purpose of the Study:

  • To review the progress and potential of somatic gene therapy targeting the hematopoietic system and liver.
  • To highlight successful gene transfer and expression in preclinical models and early human trials.

Main Methods:

  • Gene transfer into bone marrow cells and hepatocytes using recombinant retroviruses.
  • Transduction of rodent, non-human primate, and human cells.
  • In vivo transplantation of genetically modified cells into recipients.

Main Results:

Related Experiment Videos

  • Functional gene expression achieved in transduced bone marrow cells and hepatocytes.
  • Long-term survival and expression (over 6 months) observed in transplanted cells.
  • Successful transduction of human hepatocytes demonstrated.

Conclusions:

  • Somatic gene therapy targeting the hematopoietic system and liver is a viable future treatment for hereditary deficiencies.
  • Preclinical successes provide a strong foundation for ongoing human clinical trials.
  • Further research and clinical application hold significant therapeutic potential.